The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations
| Autor: | D, van Vliet, E, van der Goot, W G, van Ginkel, H J R, van Faassen, P, de Blaauw, I P, Kema, M R, Heiner-Fokkema, E A, van der Zee, F J, van Spronsen |
|---|---|
| Přispěvatelé: | Van der Zee lab, Falcao Salles lab, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Center for Liver, Digestive and Metabolic Diseases (CLDM) |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Phenylalanine
Endocrinology Diabetes and Metabolism NEUTRAL AMINO-ACIDS Biochemistry Monoaminergic neurotransmitters RECOMMENDATIONS Mouse model Mice Endocrinology Phenylketonurias Genetics Animals Humans Phenylketonuria Molecular Biology ISOLEUCINE VALINE Inborn error of metabolism ADULTS TRANSPORT TRYPTOPHAN Dietary treatment Disease Models Animal Amino Acids Neutral TYROSINE SUPPLEMENTATION PKU Dietary Supplements Brain biochemistry Large neutral amino acids RESTRICTION |
| Zdroj: | Molecular Genetics and Metabolism, 135(1), 27-34. ACADEMIC PRESS INC ELSEVIER SCIENCE |
| ISSN: | 1096-7192 |
| Popis: | BACKGROUND: Large neutral amino acid (LNAA) treatment has been suggested as alternative to the burdensome severe phenylalanine-restricted diet. While its working mechanisms and optimal composition have recently been further elucidated, the question whether LNAA treatment requires the natural protein-restricted diet, has still remained.OBJECTIVE: Firstly, to determine whether an additional liberalized natural protein-restricted diet could further improve brain amino acid and monoamine concentrations in phenylketonuria mice on LNAA treatment. Secondly, to compare the effect between LNAA treatment (without natural protein) restriction and different levels of a phenylalanine-restricted diet (without LNAA treatment) on brain amino acid and monoamine concentrations in phenylketonuria mice.DESIGN: BTBR Pah-enu2 mice were divided into two experimental groups that received LNAA treatment with either an unrestricted or semi phenylalanine-restricted diet. Control groups included Pah-enu2 mice on the AIN-93 M diet, a severe or semi phenylalanine-restricted diet without LNAA treatment, and wild-type mice receiving the AIN-93 M diet. After ten weeks, brain and plasma samples were collected to measure amino acid profiles and brain monoaminergic neurotransmitter concentrations.RESULTS: Adding a semi phenylalanine-restricted diet to LNAA treatment resulted in lower plasma phenylalanine but comparable brain amino acid and monoamine concentrations as compared to LNAA treatment (without phenylalanine restriction). LNAA treatment (without phenylalanine restriction) resulted in comparable brain monoamine but higher brain phenylalanine concentrations compared to the severe phenylalanine-restricted diet, and significantly higher brain monoamine but comparable phenylalanine concentrations as compared to the semi phenylalanine-restricted diet.CONCLUSIONS: Present results in PKU mice suggest that LNAA treatment in PKU patients does not need the phenylalanine-restricted diet. In PKU mice, LNAA treatment (without phenylalanine restriction) was comparable to a severe phenylalanine-restricted diet with respect to brain monoamine concentrations, notwithstanding the higher plasma and brain phenylalanine concentrations, and resulted in comparable brain phenylalanine concentrations as on a semi phenylalanine-restricted diet. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect